In cervical dystonia, where the chief neurophysiologic abnormality is typically excitatory, we show enhanced inhibition in a dorsal premotor to motor cortical network. Further, this enhanced inhibition was seen in a muscle not involved in the dystonic posture. This inhibition may represent a compensatory network that could be exploited for therapeutic purposes.
h i g h l i g h t s
In cervical dystonia, where the chief neurophysiologic abnormality is typically excitatory, we show enhanced inhibition in a dorsal premotor to motor cortical network. Further, this enhanced inhibition was seen in a muscle not involved in the dystonic posture. This inhibition may represent a compensatory network that could be exploited for therapeutic purposes.
a b s t r a c t
Objective: This study aims to understand whether the enhanced dPMI, seen in writer's cramp patients previously, extends to other populations of focal dystonia patients (e.g. cervical dystonia) as an endophenotypic marker. Methods: We studied 9 healthy subjects and 9 patients with CD. dPMI was tested by applying conditioning transcranial magnetic stimulation to the left dorsal premotor cortex and then a test pulse to the ipsilateral motor cortex at an interval of 6 ms. We also looked at the duration of the cortical silent period (CSP)-a measure of cortical excitability. Results: CD patients had enhanced dPMI at rest (mean 57.0%, SD 16.2) in contrast to healthy volunteers (mean 124.1%, SD 35.7) (p < 0.001). CSP latencies (in ms) in CD patients (mean 108.0, SD 33.1) were significantly shorter than in healthy volunteers (mean 159.1, SD 55.2) (p < 0.05). Conclusions: CD patients showed enhanced dPMI in a hand muscle-distant from their affected body part-similar to writer's cramp patients. This enhanced inhibition was independent of disease severity and neck posture. This suggests that enhanced dPMI may be an endophenotypic marker of dystonia. Significance: The abnormal dorsal premotor-motor connection in cervical dystonia is a potential novel and important avenue for therapeutic targeting. Ó 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Dystonia is a neurological disorder characterized by abnormal posturing due to sustained muscle contractions, which interferes with the performance of motor tasks (Breakefield et al., 2008) . Cervical dystonia (CD) emerges during middle to late adulthood and is characterized by dystonic turning and tilting of the neck (Brashear, 2009 ). This abnormal posture not only often leads to pain but also often causes significant disability in activities of daily living such as driving and reading (Brashear, 2009 ). In addition, CD can affect a patient's ability to work. In a recent retrospective cross-sectional analysis, more than half (55%) of working age patients with CD were not employed secondary to their dystonia (Martikainen et al., 2010) .
The neurophysiology of focal dystonia is characterized by loss of inhibition (Breakefield et al., 2008) . This decreased inhibition is reflected in multiple levels from abnormal patterns of muscle activity, loss of spinal and brainstem reflexes and impaired inhibition at the motor cortical level (Cohen and Hallett, 1988; Chen et al., 1995; Kanovský et al., 2003) . In contrast to this literature, we have shown in previous studies that patients with writer's cramp or focal hand dystonia consistently show enhanced dorsal premotor-motor cortical inhibition (dPMI) (Beck et al., 2009; Pirio Richardson et al., 2014) . This enhanced inhibition is hypothesized to be due to compensatory networks that play a role in
